Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.

Competing Interests: JLA reports sponsorship from Vifor Pharma for accommodation and travel to the British Society of Gastroenterology 2019 annual meeting, outside the submitted work. CPS reports grants and personal fees from AbbVie and Janssen; and personal fees from Ferring, Pfizer, Takeda, Galapagos, and Arena, outside the submitted work. NP has served as a speaker or advisory board member for Allergan, Falk, Janssen, Tillotts, Takeda, AbbVie, Debiopharm International, Ferring, Pfizer, Galapagos, and Vifor Pharma, outside the submitted work.